Scoop: Deerfield and Dana-Farber forge closer ties to launch a new translational cancer research engine
A little over two years since first teaming up on protein degradation, Deerfield and Dana-Farber are putting their heads — and their wallets — together again.
The pair is forming a new partnership in the form of Riverway Discoveries, a translational research engine aiming to boost efforts at getting preclinical cancer work into human studies. Deerfield is putting up $130 million over the next 10 years to advance such endeavors, after funding the protein degradation effort for $80 million in late 2018.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 104,800+ biopharma pros reading Endpoints daily — and it's free.